Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
The present study was carried out to determine whether a selective decrease of mitochondrial (mt) DNA-encoded cytochrome c oxidase (CCO) subunits occurs in zidovudine myopathy, as expected with a compound known to induce selective mtDNA depletion. Fourteen HIV-infected patients with zidovudine myopathy were studied. Thirteen had partial CCO deficiency assessed by histochemistry. Western blot analysis of CCO subunits (II/III, IV, Va, Vb, VIa, VIb, VIc, VIIa, VIIb, and VIIc) was performed on muscle biopsy samples. We evaluated the mtDNA-encoded subunits to nuclear DNA-encoded subunits ratio with the II/III to IV ratio. Patients had either a selective decrease of mtDNA-encoded CCO subunits (3 patients), or an overall decrease affecting both mtDNA-and nuclear DNA-encoded subunits (5 patients), or a normal expression of CCO subunits (6 patients). Positive correlations could not be established between the pattern of expression of CCO subunits and total zidovudine intake, degree of inflammation, and percentages of ragged-red fibers or CCO-deficient fibers. The finding of a decrease of both mtDNA- and nuclear DNA-encoded CCO subunits suggests that a factor additional to zidovudine could be implicated in the pathogenesis of the myopathy, at least in some patients. New insights into the pathogenesis of zidovudine myopathy might come from the use of more sensitive methods, including evaluation of CCO subunits in single fibers.
Chariot
P
P
Departments of Pathology, Neuropathology, Hôpital Henri Mondor, Créteil, France.
Bonne
G
G
Authier
F J
FJ
Marsac
C
C
Gherardi
R
R
D000328:Adult; D002467:Cell Nucleus; D030401:Cytochrome-c Oxidase Deficiency; D004272:DNA, Mitochondrial / Q000235:genetics*; D003576:Electron Transport Complex IV / Q000096:biosynthesis* / Q000235:genetics; D004790:Enzyme Induction; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008931:Mitochondria, Muscle / Q000187:drug effects* / Q000201:enzymology; D017240:Mitochondrial Myopathies / Q000139:chemically induced* / Q000201:enzymology / Q000235:genetics; D009124:Muscle Proteins / Q000096:biosynthesis* / Q000172:deficiency / Q000235:genetics; D009132:Muscles / Q000473:pathology; D006180:Proton-Translocating ATPases / Q000096:biosynthesis / Q000235:genetics; D015215:Zidovudine / Q000009:adverse effects*
D004272:DNA, Mitochondrial; D009124:Muscle Proteins; D015215:Zidovudine; D003576:Electron Transport Complex IV; D006180:Proton-Translocating ATPases